Proteomics Analysis and Identi Cation of Critical Proteins and Network
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Sanctioned Entities Name of Firm & Address Date
Sanctioned Entities Name of Firm & Address Date of Imposition of Sanction Sanction Imposed Grounds China Railway Construction Corporation Limited Procurement Guidelines, (中国铁建股份有限公司)*38 March 4, 2020 - March 3, 2022 Conditional Non-debarment 1.16(a)(ii) No. 40, Fuxing Road, Beijing 100855, China China Railway 23rd Bureau Group Co., Ltd. Procurement Guidelines, (中铁二十三局集团有限公司)*38 March 4, 2020 - March 3, 2022 Conditional Non-debarment 1.16(a)(ii) No. 40, Fuxing Road, Beijing 100855, China China Railway Construction Corporation (International) Limited Procurement Guidelines, March 4, 2020 - March 3, 2022 Conditional Non-debarment (中国铁建国际集团有限公司)*38 1.16(a)(ii) No. 40, Fuxing Road, Beijing 100855, China *38 This sanction is the result of a Settlement Agreement. China Railway Construction Corporation Ltd. (“CRCC”) and its wholly-owned subsidiaries, China Railway 23rd Bureau Group Co., Ltd. (“CR23”) and China Railway Construction Corporation (International) Limited (“CRCC International”), are debarred for 9 months, to be followed by a 24- month period of conditional non-debarment. This period of sanction extends to all affiliates that CRCC, CR23, and/or CRCC International directly or indirectly control, with the exception of China Railway 20th Bureau Group Co. and its controlled affiliates, which are exempted. If, at the end of the period of sanction, CRCC, CR23, CRCC International, and their affiliates have (a) met the corporate compliance conditions to the satisfaction of the Bank’s Integrity Compliance Officer (ICO); (b) fully cooperated with the Bank; and (c) otherwise complied fully with the terms and conditions of the Settlement Agreement, then they will be released from conditional non-debarment. If they do not meet these obligations by the end of the period of sanction, their conditional non-debarment will automatically convert to debarment with conditional release until the obligations are met. -
Table of Codes for Each Court of Each Level
Table of Codes for Each Court of Each Level Corresponding Type Chinese Court Region Court Name Administrative Name Code Code Area Supreme People’s Court 最高人民法院 最高法 Higher People's Court of 北京市高级人民 Beijing 京 110000 1 Beijing Municipality 法院 Municipality No. 1 Intermediate People's 北京市第一中级 京 01 2 Court of Beijing Municipality 人民法院 Shijingshan Shijingshan District People’s 北京市石景山区 京 0107 110107 District of Beijing 1 Court of Beijing Municipality 人民法院 Municipality Haidian District of Haidian District People’s 北京市海淀区人 京 0108 110108 Beijing 1 Court of Beijing Municipality 民法院 Municipality Mentougou Mentougou District People’s 北京市门头沟区 京 0109 110109 District of Beijing 1 Court of Beijing Municipality 人民法院 Municipality Changping Changping District People’s 北京市昌平区人 京 0114 110114 District of Beijing 1 Court of Beijing Municipality 民法院 Municipality Yanqing County People’s 延庆县人民法院 京 0229 110229 Yanqing County 1 Court No. 2 Intermediate People's 北京市第二中级 京 02 2 Court of Beijing Municipality 人民法院 Dongcheng Dongcheng District People’s 北京市东城区人 京 0101 110101 District of Beijing 1 Court of Beijing Municipality 民法院 Municipality Xicheng District Xicheng District People’s 北京市西城区人 京 0102 110102 of Beijing 1 Court of Beijing Municipality 民法院 Municipality Fengtai District of Fengtai District People’s 北京市丰台区人 京 0106 110106 Beijing 1 Court of Beijing Municipality 民法院 Municipality 1 Fangshan District Fangshan District People’s 北京市房山区人 京 0111 110111 of Beijing 1 Court of Beijing Municipality 民法院 Municipality Daxing District of Daxing District People’s 北京市大兴区人 京 0115 -
Supplementary Table 1: Genes Located on Chromosome 18P11-18Q23, an Area Significantly Linked to TMPRSS2-ERG Fusion
Supplementary Table 1: Genes located on Chromosome 18p11-18q23, an area significantly linked to TMPRSS2-ERG fusion Symbol Cytoband Description LOC260334 18p11 HSA18p11 beta-tubulin 4Q pseudogene IL9RP4 18p11.3 interleukin 9 receptor pseudogene 4 LOC100132166 18p11.32 hypothetical LOC100132166 similar to Rho-associated protein kinase 1 (Rho- associated, coiled-coil-containing protein kinase 1) (p160 LOC727758 18p11.32 ROCK-1) (p160ROCK) (NY-REN-35 antigen) ubiquitin specific peptidase 14 (tRNA-guanine USP14 18p11.32 transglycosylase) THOC1 18p11.32 THO complex 1 COLEC12 18pter-p11.3 collectin sub-family member 12 CETN1 18p11.32 centrin, EF-hand protein, 1 CLUL1 18p11.32 clusterin-like 1 (retinal) C18orf56 18p11.32 chromosome 18 open reading frame 56 TYMS 18p11.32 thymidylate synthetase ENOSF1 18p11.32 enolase superfamily member 1 YES1 18p11.31-p11.21 v-yes-1 Yamaguchi sarcoma viral oncogene homolog 1 LOC645053 18p11.32 similar to BolA-like protein 2 isoform a similar to 26S proteasome non-ATPase regulatory LOC441806 18p11.32 subunit 8 (26S proteasome regulatory subunit S14) (p31) ADCYAP1 18p11 adenylate cyclase activating polypeptide 1 (pituitary) LOC100130247 18p11.32 similar to cytochrome c oxidase subunit VIc LOC100129774 18p11.32 hypothetical LOC100129774 LOC100128360 18p11.32 hypothetical LOC100128360 METTL4 18p11.32 methyltransferase like 4 LOC100128926 18p11.32 hypothetical LOC100128926 NDC80 homolog, kinetochore complex component (S. NDC80 18p11.32 cerevisiae) LOC100130608 18p11.32 hypothetical LOC100130608 structural maintenance -
Glucocorticoid Receptor-Ppara Axis in Fetal Mouse Liver Prepares
RESEARCH ARTICLE Glucocorticoid receptor-PPARa axis in fetal mouse liver prepares neonates for milk lipid catabolism Gianpaolo Rando1†, Chek Kun Tan2†, Nourhe` ne Khaled1, Alexandra Montagner3, Nicolas Leuenberger1, Justine Bertrand-Michel4, Eeswari Paramalingam2, Herve´ Guillou3, Walter Wahli1,2,3* 1Center for Integrative Genomics, University of Lausanne, Lausanne, Switzerland; 2Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore; 3UMR 1331 ToxAlim Research Centre in Food Toxicology, INRA, Universite´ de Toulouse, Toulouse, France; 4IFR 150 Plateforme Metatoul, Institut Fe´de´ratif de Recherche Bio-Me´dicale de Toulouse INSERM U563, Toulouse, France Abstract In mammals, hepatic lipid catabolism is essential for the newborns to efficiently use milk fat as an energy source. However, it is unclear how this critical trait is acquired and regulated. We demonstrate that under the control of PPARa, the genes required for lipid catabolism are transcribed before birth so that the neonatal liver has a prompt capacity to extract energy from milk upon suckling. The mechanism involves a fetal glucocorticoid receptor (GR)-PPARa axis in which GR directly regulates the transcriptional activation of PPARa by binding to its promoter. Certain PPARa target genes such as Fgf21 remain repressed in the fetal liver and become PPARa responsive after birth following an epigenetic switch triggered by b-hydroxybutyrate-mediated inhibition of HDAC3. This study identifies an endocrine developmental axis in which fetal GR primes *For correspondence: walter. the activity of PPARa in anticipation of the sudden shifts in postnatal nutrient source and metabolic [email protected] demands. DOI: 10.7554/eLife.11853.001 †These authors contributed equally to this work Competing interests: The authors declare that no Introduction competing interests exist. -
譽宴集團控股有限公司 U Banquet Group Holding Limited
Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement. U BANQUET GROUP HOLDING LIMITED 譽宴集團控股有限公司 (incorporated in the Cayman Islands with limited liability) (Stock Code: 1483) VOLUNTARY ANNOUNCEMENT BUSINESS UPDATE This announcement is made by U Banquet Group Holding Limited (the “Company” and together with its subsidiaries, the “Group”) on a voluntary basis to keep the shareholders and potential investors of the Company informed of the latest business development of the Group. The board of directors of the Company (the “Board”) is pleased to announce that the Neijiang Urban and Rural Solid Waste Treatment PPP Project(內江城鄉生活垃圾處理PPP項目)(the “Neijiang Project”), the bid of which has been won by Aerospace Sanchuang Environmental Technoloby Chengdu CO., Ltd (“Aerospace Sanchuang”), a subsidiary of the Company, has formally entered into operation phase since July 2020. The operation period of the Neijiang Project is 22 years. The operation areas include Neijiang Economic Development Zone, Dongxing District, Zizhong County and Weiyuan County, and its scope of services covers 79 towns, 1,394 villages and 159 communities with a population of approximately 2.75 million. The daily average volume of household garbage collected and transported is 910 tons. The annual operation service fee income to be generated from the Neijiang Project is expected to be not less than RMB68 million with total service fee incomes during the operation period of not less than RMB1,500 million. -
Summary of Resettlement Plan
Resettlement Plan World Bank Loaned Small Town Development Program of Public Disclosure Authorized Sichuan Public Disclosure Authorized Resettlement Plan Public Disclosure Authorized Sichuan Wisdom Management Consulting Co., Ltd. Public Disclosure Authorized June, 2010 Sichuan Wisdom Management Consulting 1 World Bank Loaned Small Town Co., Ltd. Development Program of Sichuan Resettlement Plan Contents Summary of Resettlement Plan ................................................................................................................................. 4 Section 1 Overview ............................................................................................................................................... 7 1.1 Background ............................................................................................................................................ 7 1.2 Construction Contents ........................................................................................................................... 7 1.3 Preparation of resettlement plan .......................................................................................................... 19 1.4 Measures to minimize impact of construction ..................................................................................... 19 1.4.1 Project planning and designing stage ................................................................................................. 19 1.4.2 Engineering project implementation stage ......................................................................................... -
Homozygosity Mapping of a Dyggve-Melchior-Clausen
714 ORIGINAL ARTICLE J Med Genet: first published as 10.1136/jmg.39.10.714 on 1 October 2002. Downloaded from Homozygosity mapping of a Dyggve-Melchior-Clausen syndrome gene to chromosome 18q21.1 C Thauvin-Robinet, V El Ghouzzi, W Chemaitilly, N Dagoneau, O Boute, G Viot, A Mégarbané, A Sefiani, A Munnich, M Le Merrer, V Cormier-Daire ............................................................................................................................. See end of article for J Med Genet 2002;39:714–717 authors’ affiliations ....................... Correspondence to: Dr V Cormier-Daire, Dyggve-Melchior-Clausen syndrome (DMC) is an autosomal recessive condition characterised by short Département de trunk dwarfism, scoliosis, microcephaly, coarse facies, mental retardation, and characteristic Génétique, Hôpital radiological features. X rays show platyspondyly with double vertebral hump, epiphyseal dysplasia, Necker-Enfants Malades, irregular metaphyses, and a characteristic lacy appearance of the iliac crests. Electron microscopy of 149 rue de Sèvres, 75015 chondrocytes have shown widened cisternae of rough endoplasmic reticulum and biochemical analy- Paris, France; [email protected] ses have shown accumulation of glucosaminoglycan in cartilage, but the pathogenesis of DMC remains unexplained. Here, we report on the homozygosity mapping of a DMC gene to chromosome 18q21.1 Revised version received in seven inbred families (Zmax=9.65 at θ=0 at locus D18S1126) in the genetic interval (1.8 cM) 6 August 2002 Accepted for publication defined by loci D18S455 and D18S363. Despite the various geographical origins of the families 13 August 2002 reported here (Morocco, Tunisia, Portugal, and Lebanon), this condition was genetically homogeneous ....................... in our series. Continuing studies will hopefully lead to the identification of the disease causing gene. -
Original Article Correlation Between Mir-126 Expression and DNA Hypomethylation of CD4+ T Cells in Rheumatoid Arthritis Patients
Int J Clin Exp Pathol 2015;8(8):8929-8936 www.ijcep.com /ISSN:1936-2625/IJCEP0011813 Original Article Correlation between miR-126 expression and DNA hypomethylation of CD4+ T cells in rheumatoid arthritis patients Ge Yang1, Daoquan Wu1, Guang Zeng1, Ou Jiang1, Pingzong Yuan1, Shenjie Huang1, Jing Zhu2, Jie Tian2, Yaguang Weng2, Zhihua Rao1 1Department of Clinical Laboratory, Affiliated Second People’s Hospital of Luzhou Medical College, Neijiang 641000, China; 2Key Laboratory of Diagnostic Medicine Designated by Chinese Ministry of Education and School of Diagnostic Medicine, Chongqing Medical University, Chongqing 400016, China Received June 23, 2015; Accepted July 27, 2015; Epub August 1, 2015; Published August 15, 2015 Abstract: It has been known that the occurrence of rheumatoid arthritis (RA) was closely correlated with DNA hypo- methylation in CD4+ T cells, in which DNA methyltransferase plays a certain role. This study therefore investigated the effect of miR-126 on CD4+ T cell subgroup in RA patients and the alternation of DNA hypomethylation, in an attempt to provide new sights into the pathogenesis and treatment of RA. CD4+ T cells separated from RA patients were transfected with miRNA (miR)-126 expression vector or miR-126 inhibitor expression vector. The expression levels of CD11a, CD70 and DNMT1 mRNA were examined by real-time PCR. Protein levels of CD11a and CD70 were tested by flow cytometry while DNMT1 protein level was quantified by Western blotting. DNA was modified by sodium bisulfite and was sequenced for the methylation status of promoters of CD11a and CD70 genes. Both mRNA and protein expressions of CD11a and CD70 genes in CD4+ T cells were elevated by miR-126 transfection, along with decreased DNMT1 protein level but not mRNA level. -
Discovery Protein Names Uniprot Gene Names Average Log2 L/H
Discovery Ttest IBD vs FDR Average Log2 Average Log2 Ratio Signficant Control p adjusted p Subgroup Protein names Uniprot Gene names L/H ratio Control L/H ratio IBD ibd/control 0.05 FDR value value AUC Specific Immunolgical Aconitate hydratase, mitochondrial A2A274 ACO2 2.570537714 1.404944787 0.311737769 + 1.26481E-09 8.472E-08 0.92417 CD9 antigen A6NNI4 CD9 2.690874857 1.62514501 0.344476348 + 3.02524E-10 2.606E-08 0.95583 Calponin-2 B4DDF4 CNN2 0.388970715 0.995038293 1.833208258 + 0.000445883 0.0044168 0.755 6-phosphogluconate dehydrogenase, decarboxylating B4DQJ8 PGD -0.252090674 0.391282139 1.902888154 + 1.35886E-13 8.373E-11 0.96625 Epithelial cell adhesion molecule B5MCA4 EPCAM 3.405798843 2.468926837 0.39185163 + 0.002975231 0.0215657 0.80625 2,4-dienoyl-CoA reductase, mitochondrial B7Z6B8 DECR1 2.240008 1.557225501 0.50520929 + 0.003411719 0.023728 0.72042 Adenosylhomocysteinase;Putative adenosylhomocysteinase 3 D7UEQ7 AHCYL2 2.14170094 1.336080036 0.446810414 + 0.000222911 0.0024884 0.84583 CD44 antigen E7EPC6 CD44 1.30554758 1.619074953 1.368242916 0.094110279 0.2905348 0.62625 Lactotransferrin;Lactoferricin-H;Kaliocin-1;Lactoferroxin-A;Lactoferroxin- B;Lactoferroxin-C E7ER44 LTF 1.276691743 1.810737039 1.705818912 0.396468431 0.7158 0.59625 + Calpastatin E7ESM9 CAST 1.476781033 1.149459479 0.720851913 0.081528203 0.2635765 0.53083 Mucin-2 E7EUV1 MUC2 2.760394361 2.073574027 0.503173452 0.128786237 0.3581141 0.6325 Acyl-CoA synthetase family member 2, mitochondrial E9PF16 ACSF2 1.026815768 0.304245583 0.485502819 0.210674608 -
E2491 Public Disclosure Authorized
E2491 Public Disclosure Authorized Sichuan Small Towns Development Project by WB Loans Summary of EIA Reports (Draft) Public Disclosure Authorized Public Disclosure Authorized China Railway Eryuan Engineering Group Co., Ltd. National Environmental Impact Assessment Certificate Jia No. 3210 May 2010 Public Disclosure Authorized Contents Chapter I General ...........................................................................................................................................1 1.1 Background ................................................................................................................................................. 1 1.1.1 Project origin..................................................................................................................................1 1.1.2 Necessity of construction ...............................................................................................................1 1.2 Basis for EA Report Preparation ................................................................................................................. 1 1.2.1 PRC Laws and Regulations............................................................................................................1 1.2.2 WB Requirements ..........................................................................................................................2 1.2.3 Industry systems of the State..........................................................................................................2 1.2.4 Main technical Guides....................................................................................................................3 -
Journal of Resilience and Sustainability
www.joras.org Journal of Resilience and Sustainability Sample website http://www.aessweb.com/journals/5005/info/ia https://scholarworks.rit.edu/jes/ https://updatepublishing.com/journal/index.php/jsa/index http://www.aujst.com/ http://www.hrpub.org/journals/jour_index.php?id=95 http://sersc.org/journals/index.php/IJAST The major characteristics of our journal are as follows JORAS is a quarterly international journal. Quality is the first priority. JORAS is open access but not ask any money to author. It is trying to get top indexing services like Scopus, Web of Science, EI, and Inspec quickly. Only expert academics are considered for reviewers. It will be published in online and printed form. Limited number of the quality articles (40-50/year) will be published in each issue. Discipline wise expert member is taking care of the submitted manuscripts. Native speaker checks all the contents of the accepted manuscript. DOI will be assigned for each article for cross reference. Turnitin software is used for checking plagiarism for each manuscript. Double-blind peer review is done for submitted manuscript. Orchid ID is mandatory for corresponding author. All information of articles, reviewers and editorial board members are verified. JORAS covers resilience issues in disaster and environmental management, and education, governance, agricultural extension and sustainability. Timing of the peer review and publication is followed strictly. Resilience Global Journal of Resilience and Sustainability EISSN: - Aims and Author’s Online Resilience Home Issues International peer reviewed quarterly journal Scope guideline submission Global Journal of Resilience and Sustainability (JORAS) is a an international peer-reviewed open-access scientific journal covering all the related issues of resilience and sustainability. -
Thioesterase Induction by 2,3,7,8-Tetrachlorodibenzo-P-Dioxin
www.nature.com/scientificreports OPEN Thioesterase induction by 2,3, 7,8 ‑te tra chl orodib enz o‑ p ‑dioxin results in a futile cycle that inhibits hepatic β‑oxidation Giovan N. Cholico1,2, Russell R. Fling2,3, Nicholas A. Zacharewski1, Kelly A. Fader1,2, Rance Nault1,2 & Timothy R. Zacharewski1,2* 2,3,7,8‑Tetrachlorodibenzo‑p‑dioxin (TCDD), a persistent environmental contaminant, induces steatosis by increasing hepatic uptake of dietary and mobilized peripheral fats, inhibiting lipoprotein export, and repressing β‑oxidation. In this study, the mechanism of β‑oxidation inhibition was investigated by testing the hypothesis that TCDD dose‑dependently repressed straight‑chain fatty acid oxidation gene expression in mice following oral gavage every 4 days for 28 days. Untargeted metabolomic analysis revealed a dose‑dependent decrease in hepatic acyl‑CoA levels, while octenoyl‑ CoA and dicarboxylic acid levels increased. TCDD also dose‑dependently repressed the hepatic gene expression associated with triacylglycerol and cholesterol ester hydrolysis, fatty acid binding proteins, fatty acid activation, and 3‑ketoacyl‑CoA thiolysis while inducing acyl‑CoA hydrolysis. Moreover, octenoyl‑CoA blocked the hydration of crotonyl‑CoA suggesting short chain enoyl‑CoA hydratase (ECHS1) activity was inhibited. Collectively, the integration of metabolomics and RNA‑seq data suggested TCDD induced a futile cycle of fatty acid activation and acyl‑CoA hydrolysis resulting in incomplete β‑oxidation, and the accumulation octenoyl‑CoA levels that inhibited the activity of short chain enoyl‑CoA hydratase (ECHS1). Although the liver is the largest internal organ, it is second to adipose tissue in regard to lipid storage capacity. Approximately 15–25% (fasted vs fed state, respectively) are derived from chylomicron remnants, 5–30% (fasted vs fed state, respectively) from de novo lipogenesis, and 5–30% from visceral fat tissues 1.